表紙
市場調查報告書

敗血症醫療決策支援系統 (MDSS)的全球市場:各地區分析 (北美,歐洲,亞太地區等),未來預測 (2022年)

Medical Decision Support Systems for Sepsis Market: Revolutionary Primer for Clinical Decision Support (Market Dynamics, Case Studies, Regional Analysis (North America, Europe, Asia Pacific, Rest of the World)) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 641512
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
敗血症醫療決策支援系統 (MDSS)的全球市場:各地區分析 (北美,歐洲,亞太地區等),未來預測 (2022年) Medical Decision Support Systems for Sepsis Market: Revolutionary Primer for Clinical Decision Support (Market Dynamics, Case Studies, Regional Analysis (North America, Europe, Asia Pacific, Rest of the World)) - Global Forecast to 2022
出版日期: 2018年05月17日內容資訊: 英文 66 Pages
簡介

敗血症市場的醫療決策支持系統預計到2022年將從2017年的12.0百萬美元增至35.6百萬美元,複合年增長率為24.3%。增長可歸因於研究資金的增額,及削減醫療費·改善治療效果的壓力增加等。然而,早期診斷在嚴重性不高時便會一直出現許多警告造成患者陷入「警告疲勞」,可能會在一定程度上限制市場。

本報告提供全球敗血症MDSS (醫療決策支援系統)的市場相關分析,提供市場基本結構和最新形勢,主要市場促進·阻礙因素,市場趨勢預測 (今後6年份),各地區的詳細趨勢,主要的利用案例·成果,主要企業的簡介,今後的技術開發方向性──CDSS (臨床決策支援系統) 的演變預測──等調查。

第1章 簡介

第2章 分析方法

第3章 市場動態

  • 促進因素
    • 增加資金和研究資助
    • 削減醫療費·改善患者結果的壓力增加
  • 課題/阻礙因素
    • 緊急度低警告過年造成「警告疲勞」
    • 對不準確和不一致的資料的擔憂
  • 機會
    • CDSS (臨床決策支援系統) 用機器學習 (ML)/人工智能 (AI)

第4章 案例研究

  • WOLTERS KLUWER的POC諮詢師:幫助減少亨斯維爾醫院,阿拉巴馬州的敗血症死亡率
  • EAST JEFFERSON GENERAL HOSPITAL使用ILUMCDSSTO改善對敗血症患者治療指南的依從性
  • MOUNT SINAI MEDICAL CENTER利用CDSS的警告功能以降低敗血症的發生率

第5章 敗血症CDSS (臨床決策支援系統) 市場分析:全球/各地區

第6章 企業簡介 (產業概要,財務分析詳細內容,產品概要,近幾年趨勢)

  • WOLTERS KLUWER
  • CERNER CORPORATION
  • EPIC SYSTEMS CORPORATION
  • ROYAL PHILIPS
  • AMARA HEALTH ANALYTICS
  • MCKESSON
  • AMBIENT CLINICAL ANALYTICS
  • IATRIC SYSTEMS, INC.
  • PERAHEALTH, INC.
  • HEALTH CATALYST
  • ALLSCRIPTSHEALTHCARE SOLUTIONS
目錄
Product Code: HIT 6296

"Medical decision support systems for sepsis market is projected to register a CAGR of 24.3%."

The medical decision support systems for sepsis market is expected to reach USD 35.6 million by 2022 from USD 12.0 million in 2017, at a CAGR of 24.3%. Growth can be attributed to factors such as increasing funding and research grants, growing pressure to curb healthcare spending, and improving patient outcomes. However, alert fatigue from low-significance CDS alerts and concerns regarding inaccurate and inconsistent data are likely to restrain the market to a certain extent.

"North America to witness the highest growth during the forecast period."

Geographically, North America accounted for the largest share of the global medical decision support systems for sepsis market in 2017, followed by Europe, Asia Pacific, and the Rest of the World (RoW). North America is also expected to grow at the highest CAGR during the forecast period of 2017-2022. Factors such as increasing efforts to curb healthcare spending, federal initiatives (such as the Hospital Readmissions Reduction Program), and rising investments in HCIT solutions in the country are driving the growth of the market in this region.

Break of primary participants was as mentioned below:

  • By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
  • By Designation: Director Level: 39%, C-Level: 29%, Others: 32%
  • By Region: North America: 32%, Europe: 24%, APAC: 26%, RoW: 18%

The report includes the study of key players offering medical decision support systems for sepsis such as Wolters Kluwer Health (US), Cerner Corporation (US), Philips Healthcare (Netherlands), Amara Health Analytics (US), McKesson Corporation (US), Ambient Clinical Analytics (US), Iatric Systems Inc. (US), PeraHealth Inc. (US), Health Catalyst Inc. (US), and Allscripts Healthcare Solutions, Inc. (US).

Research Coverage:

The report segments the global medical decision support systems for sepsis market on the basis of region, with analysis and forecasts to 2022. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and market dynamics.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the solutions offered by top players in the medical decision support systems for sepsis market. The report analyzes the medical decision support systems for sepsis market, by region
  • Product Development/Innovation: Detailed insights on research and development activities and product launches in the medical decision support systems for sepsis market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the medical decision support systems for sepsis market across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the medical decision support systems for sepsis market
  • Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the medical decision support systems for sepsis market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. MARKET INTRODUCTION
  • 1.2. HISTORY OF SEPSIS MANAGEMENT

2. RESEARCH METHODOLOGY

3. MARKET DYNAMICS

  • 3.1. DRIVERS
    • 3.1.1. INCREASING FUNDING AND RESEARCH GRANTS
    • 3.1.2. GROWING PRESURE TO CURB HEALTHCARE SPENDING AND IMPROVE PATIENT OUTCOMES
  • 3.2. CHALLENGES/RESTRAINTS
    • 3.2.1. ALERT FATIGUE FROM LOW-SIGNIFICANCE CDS ALERTS
    • 3.2.2. CONCERNS REGARDING INACCRURATE AND INCONSISTENT DATA
  • 3.3. OPPORTUNITY
    • 3.3.1. MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE IN CLINICAL DECISION SUPPORT SYSTMES

4. CASE STUDIES

  • 4.1. WOLTERS KLUWER'S POC ADVISOR HELPED REDUCE SEPSIS MORTALITY RATES IN HUNTSVILLE HOSPITAL, ALABAMA
  • 4.2. EAST JEFFERSON GENERAL HOSPITAL USED ILUMCDSSTO IMPROVE ADHERENCE TO GUIDELINE-BASED CARE IN SEPSIS PATIENTS
  • 4.3. MOUNT SINAI MEDICAL CENTERUSED PREDICTIVE SCREENING ALERTS FROM CLINICAL DECISION SUPPORT (CDS) TO REDUCE SEPSIS RATES

5. SEPSIS CDSSMARKET ASSESSMENT (GLOBAL & REGIONAL)

6. COMPANY PROFILES (Business Overview, Financial Details, Product Description, Recent Developments,)*

  • 6.1. WOLTERS KLUWER
  • 6.2. CERNER CORPORATION
  • 6.3. EPIC SYSTEMS CORPORATION
  • 6.4. ROYAL PHILIPS
  • 6.5. AMARA HEALTH ANALYTICS
  • 6.6. MCKESSON
  • 6.7. AMBIENT CLINICAL ANALYTICS
  • 6.8. IATRIC SYSTEMS, INC.
  • 6.9. PERAHEALTH, INC.
  • 6.10. HEALTH CATALYST
  • 6.11. ALLSCRIPTSHEALTHCARE SOLUTIONS

*Financial Details have not ben captured in case of unlisted companies.

*Recent Developments reported in the public domain have been listed.

LIST OF TABLES

  • TABLE 1: BACTERIAL CAUSES (GRAM NEGATIVE) OF ADULT SEPSIS
  • TABLE 2: BACTERIAL CAUSES (GRAM POSITIVE) OF ADULT SEPSIS
  • TABLE 3: GLOBAL SEPSIS CDSS MARKET, BY REGION (USD MILLION)  

LIST OF FIGURES

  • FIGURE 1: CHANCES OF DEVELOPING SEPSIS INCREASE WITH AGE
  • FIGURE 2: PATIENT SURVIVAL RATE IN SEPSIS CASES
  • FIGURE 3: GLOBAL HEALTHCARE SPENDING, 2015